AUROPHARMA Aurobindo Pharma Ltd Litigation, disputes or regulatory action Announcement 2024 - FDA Warning Letter Aurobindo Pharmas Unit III at Eugia Pharma received a Warning Letter from the US FDA; however, existing supplies to the US markets remain unaffected..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Aurobindo Pharma Ltd